| MeSH term | MeSH ID | Detail |
|---|---|---|
| Carcinoma | D002277 | 18 associated lipids |
| Carcinoma, Non-Small-Cell Lung | D002289 | 72 associated lipids |
| Carcinoma, Papillary | D002291 | 3 associated lipids |
| Carcinosarcoma | D002296 | 7 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Celiac Disease | D002446 | 16 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Cherubism | D002636 | 1 associated lipids |
| Chondroblastoma | D002804 | 1 associated lipids |
| Chondrocalcinosis | D002805 | 1 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Cvija H et al. | Chemotactic and immunoregulatory properties of bone cells are modulated by endotoxin-stimulated lymphocytes. | 2012 | Inflammation | pmid:22699680 |
| Jia P et al. | The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat. | 2012 | Eur. J. Pharmacol. | pmid:22387856 |
| Terpos E et al. | Early effects of IL-6 receptor inhibition on bone homeostasis: a pilot study in women with rheumatoid arthritis. | 2011 Nov-Dec | Clin. Exp. Rheumatol. | pmid:22032557 |
| Arikan F et al. | C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis: a case-control study. | 2011 Mar-Apr | Int J Oral Maxillofac Implants | pmid:21483881 |
| Crespi R et al. | Corticocancellous porcine bone in the healing of human extraction sockets: combining histomorphometry with osteoblast gene expression profiles in vivo. | 2011 Jul-Aug | Int J Oral Maxillofac Implants | pmid:21841997 |
| Franke S et al. | Advanced glycation end products affect growth and function of osteoblasts. | 2011 Jul-Aug | Clin. Exp. Rheumatol. | pmid:21906430 |
| Rezg R et al. | Inhibitors of vascular calcification as potential therapeutic targets. | 2011 Jul-Aug | J. Nephrol. | pmid:21688249 |
| Reyes-GarcÃa R et al. | [Cardiovascular disease and bone metabolism]. | 2011 Aug-Sep | Endocrinol Nutr | pmid:21775224 |
| Ostrowska Z et al. | Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women. | 2011 | Postepy Hig Med Dosw (Online) | pmid:22100799 |
| Kurabayashi M | [Bone and calcium update; diagnosis and therapy of bone metabolism disease update. Calcification of atherosclerotic plaques: mechanism and clinical significance]. | 2011 | Clin Calcium | pmid:22133823 |
| Tsioufis C et al. | Relationships of osteoprotegerin with albuminuria and asymmetric dimethylarginine in essential hypertension: integrating vascular dysfunction. | 2011 | Expert Opin. Ther. Targets | pmid:22136618 |
| Zhou J et al. | Expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in root resorption induced by heavy force in rats. | 2011 | J Orofac Orthop | pmid:22138776 |
| Grzibovskis M et al. | Specific signaling molecule expressions in the interradicular septum in different age groups. | 2011 | Stomatologija | pmid:22071415 |
| Stein SH and Tipton DA | Vitamin D and its impact on oral health--an update. | 2011 | J Tenn Dent Assoc | pmid:21748977 |
| Xie H et al. | Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. | 2011 | Cardiovasc. Res. | pmid:21750093 |
| Wang Y et al. | Alendronate (ALN) combined with osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats. | 2011 | J Orthop Surg Res | pmid:21752290 |
| Plasilova M et al. | Discordant gene expression signatures and related phenotypic differences in lamin A- and A/C-related Hutchinson-Gilford progeria syndrome (HGPS). | 2011 | PLoS ONE | pmid:21738662 |
| Ren G et al. | Simultaneous administration of fluoride and selenite regulates proliferation and apoptosis in murine osteoblast-like MC3T3-E1 cells by altering osteoprotegerin. | 2011 | Biol Trace Elem Res | pmid:21739163 |
| Sylvester FA et al. | Fecal osteoprotegerin may guide the introduction of second-line therapy in hospitalized children with ulcerative colitis. | 2011 | Inflamm. Bowel Dis. | pmid:21744427 |
| Weinstein RS et al. | Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice. | 2011 | Endocrinology | pmid:21771887 |
| Tipton DA et al. | Effect of bisphosphonates on human gingival fibroblast production of mediators of osteoclastogenesis: RANKL, osteoprotegerin and interleukin-6. | 2011 | J. Periodont. Res. | pmid:20701670 |
| Lee JH et al. | Tumor necrosis factor-α converting enzyme (TACE) increases RANKL expression in osteoblasts and serves as a potential biomarker of periodontitis. | 2011 | BMB Rep | pmid:21777519 |
| Baldi D et al. | Dental implants osteogenic properties evaluated by cDNA microarrays. | 2011 | Implant Dent | pmid:21778890 |
| Nakashima A et al. | Plasma osteoprotegerin, arterial stiffness, and mortality in normoalbuminemic Japanese hemodialysis patients. | 2011 | Osteoporos Int | pmid:20812007 |
| Chen WF et al. | Total flavonoid fraction of the Herba epimedii extract suppresses urinary calcium excretion and improves bone properties in ovariectomised mice. | 2011 | Br. J. Nutr. | pmid:20815976 |
| Zinonos I et al. | Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo. | 2011 | J. Bone Miner. Res. | pmid:20818644 |
| Tao H et al. | P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption. | 2011 | PLoS ONE | pmid:21886782 |
| Lawrie A et al. | Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner. | 2011 | Am. J. Pathol. | pmid:21835155 |
| Poulsen MK et al. | Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus. | 2011 | Cardiovasc Diabetol | pmid:21838881 |
| Markatseli AE et al. | Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women. | 2011 | Maturitas | pmid:21840657 |
| Kauther MD et al. | Calcitonin substitution in calcitonin deficiency reduces particle-induced osteolysis. | 2011 | BMC Musculoskelet Disord | pmid:21843355 |
| Gradosova I et al. | The role of atorvastatin in bone metabolism in male albino Wistar rats. | 2011 | Pharmazie | pmid:21901984 |
| Straface G et al. | Assessment of the genetic effects of polymorphisms in the osteoprotegerin gene, TNFRSF11B, on serum osteoprotegerin levels and carotid plaque vulnerability. | 2011 | Stroke | pmid:21903966 |
| Mamalis AA et al. | Chemical modification of an implant surface increases osteogenesis and simultaneously reduces osteoclastogenesis: an in vitro study. | 2011 | Clin Oral Implants Res | pmid:21070383 |
| Vitoratos N et al. | Maternal circulating osteoprotegerin and soluble RANKL in pre-eclamptic women. | 2011 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:21074311 |
| Belibasakis GN et al. | Oral biofilm challenge regulates the RANKL-OPG system in periodontal ligament and dental pulp cells. | 2011 | Microb. Pathog. | pmid:21075196 |
| Wattanaroonwong N et al. | Oestrogen inhibits osteoclast formation induced by periodontal ligament fibroblasts. | 2011 | Arch. Oral Biol. | pmid:21035111 |
| D'Amelio P et al. | Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures. | 2011 | Osteoporos Int | pmid:21116815 |
| Kaneko K and Kawai S | [Mechanisms and therapeutics of glucocorticoid-induced osteoporosis]. | 2011 | Nihon Rinsho Meneki Gakkai Kaishi | pmid:21720102 |
| Zhang Y et al. | Study of the mechanisms by which Sambucus williamsii HANCE extract exert protective effects against ovariectomy-induced osteoporosis in vivo. | 2011 | Osteoporos Int | pmid:20414641 |
| Hie M and Tsukamoto I | Vitamin C-deficiency stimulates osteoclastogenesis with an increase in RANK expression. | 2011 | J. Nutr. Biochem. | pmid:20444587 |
| Belibasakis GN et al. | Porphyromonas gingivalis induces RANKL in T-cells. | 2011 | Inflammation | pmid:20446027 |
| Clézardin P | [The role of RANK/RANKL/osteoprotegerin (OPG) triad in cancer-induced bone diseases: physiopathology and clinical implications]. | 2011 | Bull Cancer | pmid:21700551 |
| Celczyńska Bajew L et al. | The effects of osteoprotegerin (OPG) gene polymorphism in patients with ischaemic heart disease on the morphology of coronary arteries and bone mineral density. | 2011 | Kardiol Pol | pmid:21678294 |
| Dzida G | [Decalcified bones, calcified heart?]. | 2011 | Kardiol Pol | pmid:21678295 |
| Yang Q et al. | Plasma osteoprotegerin levels and long-term prognosis in patients with intermediate coronary artery lesions. | 2011 | Clin Cardiol | pmid:21678453 |
| Toffoli B et al. | Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop. | 2011 | Atherosclerosis | pmid:21679949 |
| de Moraes M et al. | Comparative immunohistochemical expression of RANK, RANKL and OPG in radicular and dentigerous cysts. | 2011 | Arch. Oral Biol. | pmid:21683340 |
| Ndip A et al. | The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. | 2011 | Diabetes | pmid:21659498 |
| Gulseren A et al. | Evaluation of weekly risedronate treatment in postmenopausal women with osteoprotegerin. | 2011 | Panminerva Med | pmid:21659972 |
| Corallini F et al. | Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells. | 2011 | J. Cell. Physiol. | pmid:21660951 |
| Costa-Rodrigues J and Fernandes MH | Paracrine-mediated differentiation and activation of human haematopoietic osteoclast precursor cells by skin and gingival fibroblasts. | 2011 | Cell Prolif. | pmid:21535267 |
| Lee YS and Choi EM | Apocynin stimulates osteoblast differentiation and inhibits bone-resorbing mediators in MC3T3-E1 cells. | 2011 | Cell. Immunol. | pmid:21683946 |
| Quemerais-Durieu MA et al. | [Therapeutic innovation in osteoporosis (antisclerostin antibody and denosumab)]. | 2011 | Ann. Endocrinol. (Paris) | pmid:22008272 |
| Koo HM et al. | Elevated osteoprotegerin is associated with inflammation, malnutrition and new onset cardiovascular events in peritoneal dialysis patients. | 2011 | Atherosclerosis | pmid:22015178 |
| Cao H et al. | Dysregulated atrial gene expression of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand axis in the development and progression of atrial fibrillation. | 2011 | Circ. J. | pmid:22001292 |
| Scialla JJ et al. | Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease. | 2011 | Clin J Am Soc Nephrol | pmid:21940840 |
| Sfiridaki K et al. | Angiogenesis-related cytokines, RANKL, and osteoprotegerin in multiple myeloma patients in relation to clinical features and response to treatment. | 2011 | Mediators Inflamm. | pmid:21941412 |
| Bao L et al. | Anthraquinone compounds from Morinda officinalis inhibit osteoclastic bone resorption in vitro. | 2011 | Chem. Biol. Interact. | pmid:21945525 |
| Zhou XW et al. | [Expressions of RANK, RANKL, and osteoprotegerin in male rats at different ages]. | 2011 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:21945761 |
| Carmona-Fernandes D et al. | Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients. | 2011 | Arthritis Res. Ther. | pmid:22027240 |
| Wang Y et al. | [Interleukin-4 and osteoprotegerin suppress polyethylene wear debris-induced osteolysis in a murine air pouch model]. | 2011 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:22027773 |
| Wang JZ et al. | [Effect of Epimedium extract on osteoprotegerin and RANKL mRNA expressions in glucocorticoid-induced femoral head necrosis in rats]. | 2011 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:22027774 |
| Mencej-BedraÄ S et al. | TNFRSF11B gene polymorphisms 1181G > C and 245T > G as well as haplotype CT influence bone mineral density in postmenopausal women. | 2011 | Maturitas | pmid:21411255 |
| Lee JC et al. | Role of RANK-RANKL-OPG axis in cranial suture homeostasis. | 2011 | J Craniofac Surg | pmid:21415639 |
| Ferrari-Lacraz S and Ferrari S | Do RANKL inhibitors (denosumab) affect inflammation and immunity? | 2011 | Osteoporos Int | pmid:20571772 |
| Goto H et al. | Human bone marrow adipocytes support dexamethasone-induced osteoclast differentiation and function through RANKL expression. | 2011 | Biomed. Res. | pmid:21383509 |
| Belibasakis GN et al. | The RANKL-OPG system is differentially regulated by supragingival and subgingival biofilm supernatants. | 2011 | Cytokine | pmid:21474331 |
| Siomou E et al. | Serum osteoprotegerin, RANKL and fibroblast growth factor-23 in children with chronic kidney disease. | 2011 | Pediatr. Nephrol. | pmid:21479768 |
| Sexton WM et al. | Salivary biomarkers of periodontal disease in response to treatment. | 2011 | J. Clin. Periodontol. | pmid:21480939 |
| Cordeiro MM et al. | Primary teeth show less protecting factors against root resorption. | 2011 | Int J Paediatr Dent | pmid:21481035 |
| Yang Z et al. | [Effects of negative pressure on osteogenesis in human bone marrow-derived stroma cells cultured in vitro]. | 2011 | Zhongguo Gu Shang | pmid:22276514 |
| Hall J et al. | A controlled clinical exploratory study on genetic markers for peri-implantitis. | 2011 | Eur J Oral Implantol | pmid:22282733 |
| Xu ML et al. | [An update for the research progress of osteoprotegerin on coronary artery disease]. | 2011 | Zhonghua Xin Xue Guan Bing Za Zhi | pmid:22321243 |
| Kim H et al. | Association between Wnt signaling pathway gene polymorphisms and bone response to hormone therapy in postmenopausal Korean women. | 2011 | Menopause | pmid:21471826 |
| Mulcahy LE et al. | RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells. | 2011 | Bone | pmid:20854946 |
| Aspenberg P et al. | Targeting RANKL for reduction of bone loss around unstable implants: OPG-Fc compared to alendronate in a model for mechanically induced loosening. | 2011 | Bone | pmid:20858557 |
| Kurnatowska I et al. | Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients. | 2011 | Nephron Clin Pract | pmid:20861651 |
| de Souza Faloni AP et al. | Jaw and long bone marrows have a different osteoclastogenic potential. | 2011 | Calcif. Tissue Int. | pmid:20862464 |
| Park JS et al. | Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus. | 2011 | Eur. J. Endocrinol. | pmid:20961967 |
| Andersen GØ et al. | Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size. | 2011 | Heart | pmid:21270073 |
| Tsukamoto S et al. | Clinical significance of osteoprotegerin expression in human colorectal cancer. | 2011 | Clin. Cancer Res. | pmid:21270110 |
| Monnouchi S et al. | The roles of angiotensin II in stretched periodontal ligament cells. | 2011 | J. Dent. Res. | pmid:21270461 |
| Chang YH et al. | Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy. | 2011 | Metab. Clin. Exp. | pmid:21251686 |
| Benslimane-Ahmim Z et al. | Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colony-forming cells properties. | 2011 | J. Thromb. Haemost. | pmid:21255246 |
| WaluÅ›-Miarka M et al. | Osteoprotegerin is associated with markers of atherosclerosis and body fat mass in type 2 diabetes patients. | 2011 | Int. J. Cardiol. | pmid:21255853 |
| Saito CT et al. | Effect of low-level laser therapy on the healing process after tooth replantation: a histomorphometrical and immunohistochemical analysis. | 2011 | Dent Traumatol | pmid:21244626 |
| Erkol A et al. | Relation of circulating osteoprotegerin levels on admission to microvascular obstruction after primary percutaneous coronary intervention. | 2011 | Am. J. Cardiol. | pmid:21247537 |
| Piedra M et al. | "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density". | 2011 | BMC Med. Genet. | pmid:22185226 |
| Kawaguchi H | [Approach for therapeutic targets of osteoarthritis]. | 2011 | Nippon Yakurigaku Zasshi | pmid:21747205 |
| Hou WW et al. | Involvement of Wnt activation in the micromechanical vibration-enhanced osteogenic response of osteoblasts. | 2011 | J Orthop Sci | pmid:21833614 |
| Nahidi L et al. | Osteoprotegerin in pediatric Crohn's disease and the effects of exclusive enteral nutrition. | 2011 | Inflamm. Bowel Dis. | pmid:20848544 |
| Watkins M et al. | Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling. | 2011 | Mol. Biol. Cell | pmid:21346198 |
| Confavreux CB | Bone: from a reservoir of minerals to a regulator of energy metabolism. | 2011 | Kidney Int. Suppl. | pmid:21346725 |
| Caetano-Lopes J et al. | Upregulation of inflammatory genes and downregulation of sclerostin gene expression are key elements in the early phase of fragility fracture healing. | 2011 | PLoS ONE | pmid:21347301 |
| Assmann G et al. | Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: a case-control study. | 2011 | J. Dermatol. | pmid:21352301 |
| Audo R et al. | Mechanisms and clinical relevance of TRAIL-triggered responses in the synovial fibroblasts of patients with rheumatoid arthritis. | 2011 | Arthritis Rheum. | pmid:21305500 |
| Alexander KA et al. | Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. | 2011 | J. Bone Miner. Res. | pmid:21305607 |
| Lau CP et al. | Pamidronate, farnesyl transferase, and geranylgeranyl transferase-I inhibitors affects cell proliferation, apoptosis, and OPG/RANKL mRNA expression in stromal cells of giant cell tumor of bone. | 2011 | J. Orthop. Res. | pmid:20886653 |
| Ignatius A et al. | Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1β. | 2011 | J. Cell. Biochem. | pmid:21598302 |